Community Capital Management’s Edwards Lifesciences EW Stock Holding History

Community Capital Management’s Portfolio EW Stock Details EW Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q3	–	Sell	-3,810	Closed	-$395K	–	92
2021 Q2	$395K	Hold	3,810	–	–	0.4%	72
2021 Q1	$319K	Hold	3,810	–	–	0.35%	73
2020 Q4	$348K	Hold	3,810	–	–	0.42%	68
2020 Q3	$304K	Hold	3,810	–	–	0.4%	71
2020 Q2	$263K	Hold	3,810	–	–	0.29%	95
2020 Q1	$240K	Hold	3,810	–	–	0.4%	70
2019 Q4	$296K	Sell	3,810 -3,810	-50%	-$298K	0.28%	92
2019 Q3	$559K	Buy	7,620 +2,472	+48%	+$174K	0.61%	52
2019 Q2	$317K	Buy	+5,148	New	+$311K	0.36%	80
2019 Q1	–	Sell	-5,148	Closed	-$263K	–	166
2018 Q4	$263K	Buy	+5,148	New	+$260K	0.39%	80

Other funds holding EW

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Brown Advisory Baltimore, Maryland $64.6B AUM 18.98% 1-Year Est. Return

Sands Capital Management Arlington, Virginia $26.9B AUM 34.44% 1-Year Est. Return

AllianceBernstein Nashville, Tennessee $302B AUM 26.44% 1-Year Est. Return

Janus Henderson Group London $209B AUM 37.72% 1-Year Est. Return

Community Capital Management's EW Position: Q3 2021 in Review

Community Capital Management sold out of Edwards Lifesciences (EW) in Q3 2021, closing a stake of 3,810 shares — an estimated $395K sold.

Community Capital Management first reported a position in EW in Q4 2018 and held it in 10 quarters. The position peaked at $559K in Q3 2019. 1,229 funds tracked by Wall St. Rank hold EW as of Q3 2021.

Community Capital Management reported no remaining Edwards Lifesciences position as of Q3 2021 after selling out during the quarter.
Community Capital Management sold 3,810 Edwards Lifesciences shares in Q3 2021, an estimated $395K.
Community Capital Management first reported a position in Edwards Lifesciences in Q4 2018 and held it in 10 quarters.
Community Capital Management's Edwards Lifesciences position peaked at $559K in Q3 2019.
1,229 funds tracked by Wall St. Rank held Edwards Lifesciences as of Q3 2021.

Based on Community Capital Management's 13F filing for Q3 2021, filed 14 Oct 2021.